CCL vs TBPH · P/E 15, rev $12.83B vs P/E 7.5, rev $38.4M
Carnival Corporation (CCL) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported CCL revenue for 2026-05-31 was $12.83B. Net income was $795.0M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the CCL and TBPH stock pages for the full models.
Not investment advice.